As Co-founder and Chief Executive Officer of Nanoscope Therapeutics, Sulagna Bhattacharya leads a talented and diverse team dedicated to the development of sight-restoring therapies for the millions of patients worldwide blinded by inherited retinal diseases for which no cure exists. Ms. Bhattacharya is a serial entrepreneur having co-founded several biotech and biomedical device/diagnostic companies. Before entering the biotechnology world, Ms. Bhattacharya had decades of experience in management consulting at Deloitte and Hitachi Consulting. Her specialties included business intelligence and risk management. She played a key role in seven full life cycle project implementations including multi-billion-dollar mergers and acquisitions and later founded a Management Consulting Company. Ms. Bhattacharya has been recognized as an EY Entrepreneur of the Year regional winner (2022) and a Top 25 Women Leaders in Biotechnology for 2023.